DeepHealth receives FDA clearance for AI-powered breast ultrasound software

DeepHealth received FDA 510(k) clearance for its AI-powered breast ultrasound software, designed to assist lesion detection and reporting, improving breast cancer detection sensitivity and reducing radiologist interpretation time. The software is now commercially available in the U.S. and may qualify for reimbursement, with deployment planned across RadNet's imaging network.

This Wire brief sits within Fusion42's coverage of Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.